MedTrace Logo

Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer

NCT00534196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6927

Last updated 2023-06-26

No results posted yet for this study

Summary

RATIONALE: Implant radiation therapy delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

PURPOSE: This clinical trial is studying the side effects and how well implant radiation therapy using radioactive iodine works in treating patients with localized prostate cancer.

Conditions

Interventions

RADIATION

Permanent iodine-125 (Brachytherapy)

Observational research was conducted by grouping Brachytherapy with/without PI (permanent iodine) seed implantation.

Sponsors & Collaborators

  • Kurosawa Hospital

    collaborator UNKNOWN

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Shiro Saito, MD, PhD · National Hospital Organization Tokyo Medical Center

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2016-11-30
Completion
2021-12-13

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00534196 on ClinicalTrials.gov